Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 28;16(10):e0010871.
doi: 10.1371/journal.pntd.0010871. eCollection 2022 Oct.

Inter-epidemic Rift Valley fever virus infection incidence and risks for zoonotic spillover in northern Tanzania

Affiliations

Inter-epidemic Rift Valley fever virus infection incidence and risks for zoonotic spillover in northern Tanzania

William A de Glanville et al. PLoS Negl Trop Dis. .

Abstract

Rift Valley fever virus (RVFV) is a mosquito-borne pathogen that has caused epidemics involving people and animals across Africa and the Arabian Peninsula. A number of studies have found evidence for the circulation of RVFV among livestock between these epidemics but the population-level incidence of infection during this inter-epidemic period (IEP) is rarely reported. General force of infection (FOI) models were applied to age-adjusted cross-sectional serological data to reconstruct the annual FOI and population-level incidence of RVFV infection among cattle, goats, and sheep in northern Tanzania from 2009 through 2015, a period without reported Rift Valley fever (RVF) cases in people or animals. To evaluate the potential for zoonotic RVFV spillover during this period, the relationship between village-level livestock RVFV FOI and human RVFV seropositivity was quantified using multi-level logistic regression. The predicted average annual incidence was 72 (95% Credible Interval [CrI] 63, 81) RVFV infections per 10,000 animals and 96 (95% CrI 81, 113), 79 (95% CrI 62, 98), and 39 (95% CrI 28, 52) per 10,000 cattle, sheep, and goats, respectively. There was variation in transmission intensity between study villages, with the highest estimated village-level FOI 2.49% (95% CrI 1.89, 3.23) and the lowest 0.12% (95% CrI 0.02, 0.43). The human RVFV seroprevalence was 8.2% (95% Confidence Interval 6.2, 10.9). Human seropositivity was strongly associated with the village-level FOI in livestock, with the odds of seropositivity in an individual person increasing by around 1.2 times (95% CrI 1.1, 1.3) for each additional annual RVFV seroconversion per 1,000 animals. A history of raw milk consumption was also positively associated with human seropositivity. RVFV has circulated at apparently low levels among livestock in northern Tanzania in the period since the last reported epidemic. Although our data do not allow us to confirm human RVFV infections during the IEP, a strong association between human seropositivity and the FOI in cattle, goats, and sheep supports the hypothesis that RVFV circulation among livestock during the IEP poses a risk for undetected zoonotic spillover in northern Tanzania. We provide further evidence for the likely role of raw milk consumption in RVFV transmission from animals to people.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Number of cattle, goats, and sheep sampled by age from two cross-sectional serosurveys conducted in 2013 through 2016 in Arusha, Manyara and Kilimanjaro Regions, Tanzania.
Fig 2
Fig 2. Predicted RVFV seroprevalence (red line) and 95% credible intervals (grey line) by age on the basis of catalytic models for cattle, goats and sheep using data collected in northern Tanzania from 2013 through 2016.
Observed seroprevalence by age for each species is overlaid as black circles.
Fig 3
Fig 3. Variation in the village-level annual predicted force of infection (FOI) of Rift Valley fever virus among livestock between 2009 and 2015 in Arusha, Manyara and Kilimanjaro Regions of northern Tanzania.
Map created using QGIS version 3.22.1. Base layer from GADM (https:gadm.org/).

References

    1. Kariuki Njenga M, Bett B. Rift Valley Fever Virus—How and Where Virus Is Maintained During Inter-epidemic Periods. Curr Clin Micro Rpt. 2019;6: 18–24. doi: 10.1007/s40588-018-0110-1 - DOI
    1. Linthicum KJ, Kaburia HF, Davies FG, Lindqvist KJ. A blood meal analysis of engorged mosquitoes found in Rift Valley fever epizootics area in Kenya. J Am Mosq Control Assoc. 1985;1: 93–95. - PubMed
    1. Anyamba A, Linthicum KJ, Mahoney R, Tucker CJ, Kelley PW. Mapping Potential Risk of Rift Valley Fever Outbreaks in African Savannas Using Vegetation Index Time Series Data. Photogramm Eng Remote Sensing. 2002;68: 137–145.
    1. Sindato C, Karimuribo ED, Pfeiffer DU, Mboera LEG, Kivaria F, Dautu G, et al.. Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007. PLoS One. 2014;9: e88897. doi: 10.1371/journal.pone.0088897 - DOI - PMC - PubMed
    1. Sindato C, Karimuribo E, Mboera LEG. The epidemiology and socio-economic impact of rift valley fever epidemics in Tanzania: a review. Tanzan J Health Res. 2011;13: 305–318. doi: 10.4314/thrb.v13i5.1 - DOI - PubMed

Publication types

Substances